Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
Titel:
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
Auteur:
Vokes, E.E. Ready, N. Felip, E. Horn, L. Burgio, M.A. Antonia, S.J. Arén Frontera, O. Gettinger, S. Holgado, E. Spigel, D. Waterhouse, D. Domine, M. Garassino, M. Chow, L.Q.M. Blumenschein Jr, G. Barlesi, F. Coudert, B. Gainor, J. Arrieta, O. Brahmer, J. Butts, C. Steins, M. Geese, W.J. Li, A. Healey, D. Crinò, L.